Chronic pains: It just got harder for tourists to legally buy cannabis in Thailand
As of Thursday, customers need a doctor's prescription to buy cannabis — effectively restricting consumption of the plant to medical and health purposes only.
Thailand's public health minister told CNN on Wednesday he hopes to eventually recriminalize cannabis as a narcotic, in what would be a major reversal from Thailand's liberal approach since declassification, which saw a boom of dispensaries and weed cafes opening across the country, particularly in tourist areas.
'This must be clearly understood: cannabis is permitted for medical use only,' Public Health Minister Somsak Thepsutin told CNN.
The new rules from Thailand's Health Ministry aim to enforce the regulation of cannabis as a controlled herb.
That means licensed cannabis shops can now only sell to customers with a medical prescription. They are also required to keep detailed sales records and face regular inspections by authorities, Somsak said. New rules also put stricter controls on growers and farmers, ban commercial advertising and prohibit cannabis from being sold in vending machines or online.
More than 18,000 licensed cannabis shops across the country will have to adapt or risk closing. Penalties for sellers caught violating the new rules include up to one year in prison or a fine of 20,000 baht ($620), though the health ministry is proposing new legislation that would significantly increase this.
The ban on advertising may also dramatically change the landscape of tourist hotspots such as Khao San Road in the capital Bangkok, or beach towns like Pattaya, where hundreds of cannabis shops and cafes line the streets with their green neon signs, cannabis-shaped inflatables and catchy slogans enticing tourists to get high.
Now, tourists and locals will need a doctor's certificate from Thailand or their home country to purchase cannabis buds to treat certain conditions such as nausea from chemotherapy, drug-resistant epilepsy or nerve pain.
'We want to tell tourists they are welcome to enjoy Thailand's culture and nature — but Thailand should not be seen as a destination for recreational cannabis use,' Somsak said.
Medical marijuana has been legal in Thailand since 2018, but decriminalization in 2022 meant it was no longer a crime to grow and trade marijuana or hemp products, or to use any parts of the plant to treat illnesses — a major move in a region notorious for harsh penalties towards illegal drugs.
Following legalization, the government intended to regulate the industry. But a legal vacuum emerged when this failed to materialize, and recreational use exploded across the kingdom, particularly in areas popular with foreigners.
Thousands of cannabis dispensaries sprang up, as well as other cannabis-themed businesses like weed cafes, hemp spas and places offering beauty treatments. Cities like Chiang Mai and Bangkok have even held weed festivals, and decriminalization has been a major draw for tourists.
One such festival in Bangkok earlier this month boasted an appearance by Mike Tyson, who has launched his own brand of boxing glove- and ear-shaped cannabis gummies.
A 2022 report released by Thailand's Ministry of Commerce estimated the industry could be worth $1.2 billion by 2025, though Somsak said there is currently 'no clear estimate' of the industry's value 'due to unregulated transactions.'
Somsak said the new rules help plug that legal vacuum and prevent misuse.
'We are not shutting down cannabis shops, but we are prioritizing medical regulation,' he said.
'Revenue may dip at first, but considering the social harm caused by unregulated use, the change is necessary … responsible, law-abiding businesses will remain stable and continue operating.'
Those in support of greater regulation say the industry has grown out of control, and cited health concerns, cannabis use among children, and addiction, while complaints of tourists smoking in the street are reportedly growing on the Thai islands.
On the holiday island of Phuket, a plan has been proposed that would establish zones restricting where cannabis could be bought and sold.
'Right now, cannabis addiction is rising and has become a social issue. It affects children, causes nuisance from unwanted odors,' said Somsak.
'Public safety must come first… the current cannabis industry is made up of scattered, unregulated shops.'
Adding to the issue, cannabis smuggling has soared since legalization.
Several high-profile cases involving young, British women have made headlines this year, all originating in Thailand.
The issue got so bad that British and Thai authorities formed a joint task force to halt the increase in drugs being smuggled out by tourists and by mail from Thailand to the UK, with Thailand enforcing stricter screening measures at its borders.
Between October 2024 and March 2025, more than 800 cannabis smugglers were arrested and over nine metric tons of cannabis were seized, according to the British government.
Cannabis advocates have argued that the boom across Thailand has helped many Thais, from farmers to small business owners and workers behind the counter.
Some sellers are now scrambling to understand what the new regulations will mean for their business.
'The lack of clarity in the law has already caused worry,' said Ake Khattiyadamrong, a cannabis shop owner in eastern Thailand's Chonburi province.
'It's a real shame — Thailand was actually one of the first countries in the world to recognize the benefits of cannabis and legalize it. But once it was legalized, state officials failed to follow through.
'There was no real effort to educate the public. The ministerial regulations that were issued weren't seriously enforced either.'
Cannabis advocates say the new regulations won't stop smuggling or unlicensed growers, and risk driving up corruption.
'This is a knee-jerk reaction to supposedly addressing the smuggling issue,' said Kitty Chopaka, a longtime cannabis activist with the Writing Thailand's Cannabis Future Network advocacy group, which pushes for fair access.
Chopaka argues that many shops are operating without licenses and sell products such as gummies and edibles that are technically illegal though readily available.
'The police don't shut them down,' she said.
If the government enforced the 'rules and laws that currently exist, the issue that they are now saying needs to be fixed wouldn't have existed,' she added.
Ake, the shop owner, said requiring a doctor's note to purchase cannabis will not stop people from buying for recreational purposes.
'Everyone knows medical certificates can be bought, so this just creates a new revenue stream for certain doctors … It burdens consumers with extra costs for accessing cannabis, especially during Thailand's current economic struggles and global economic issues,' he said.
Ake welcomes regulations that create stability in the industry but wants to see clear, well-rounded laws that are fair to everyone.
'Everything must be traceable and truly safe. I believe that's the core principle. It's not about selling cheap, illegal products. Those can't guarantee user safety,' he said.
Since legalization, overproduction of cannabis has saturated the market and driven down prices so cannabis sellers were already taking a hit to their earnings.
'There's not enough sales, the cost of weed is very cheap, and people who live here buy directly from the farms,' said Chopaka, who recently had to close her shop due to low prices and undercutting from bigger sellers.
There have been several attempts to pass legislation regulating the cannabis industry. The ruling Pheu Thai Party proposed criminalizing the drug again last year but faced opposition from its coalition partner the Bhumjaithai Party, which spearheaded the original legalization.
The latest push from Somsak comes after Bhumjaithai pulled out of the coalition government last week.
He said the new regulations are just a first step — but acknowledged getting a bill through parliament will take time.
'This isn't a fixed policy that can't be changed,' he said.
'Without legal control, investment or business operations — no matter the country — must be cautious. If the investment is related to narcotics or controlled substances, there must be clear laws.'
But Chopaka fears the new regulations will only make it harder for the smaller farmers to survive.
'I want to see fair access. I want to see rules that make sense,' she said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
3 hours ago
- Bloomberg
FDA Warns Against Eating Shrimp Brand, Citing Radioactive Matter
The US Food and Drug Administration has advised the public not to eat a brand of shrimp sold at Walmart Inc. over concerns about radioactive contamination. The agency told Walmart to pull three lots of raw frozen shrimp sourced from Indonesia after officials detected radioactive Cesium-137 in a shipment that did not enter the US, the FDA said in a statement on Tuesday. The isotope can lead to an elevated risk of cancer through repeated exposure to low doses, though the detected levels were not high enough to cause an acute risk, the FDA said.
Medscape
4 hours ago
- Medscape
Rivaroxaban or Combo Therapy: A Winner for All Ages?
TOPLINE: In patients with atrial fibrillation (AF) and stable coronary artery disease (CAD), rivaroxaban monotherapy reduced the risks for major cardiovascular events (MACE) and major bleeding across all adult age groups. METHODOLOGY: Researchers performed a post hoc analysis of data from the AFIRE trial, conducted in Japan, to assess the age-stratified effects of rivaroxaban monotherapy vs treatment with rivaroxaban plus an antiplatelet agent. The analysis included 2215 patients (mean age, 74.3 years; 79.1% men) with AF and stable CAD more than 1 year after revascularization or angiographically confirmed CAD that did not need revascularization. Patients were randomly assigned to 10 mg or 15 mg of rivaroxaban monotherapy, depending on creatinine clearance, or combination therapy involving rivaroxaban plus aspirin or a P2Y12 inhibitor (at the physician's discretion). The patients were stratified into four age groups: younger than 70 years, 70-74 years, 75-79 years, and 80 years or older. The primary efficacy endpoint was MACE, defined as a composite of stroke, myocardial infarction, systemic embolism, unstable angina requiring revascularization, or death; the primary safety endpoint was major bleeding. The patients were followed for up to 45 months. TAKEAWAY: Across the age spectrum, rivaroxaban alone matched combination therapy for reducing the risks for MACE and major bleeding. However, rivaroxaban monotherapy, compared with combination therapy, was associated with a more pronounced reduction in the risk for MACE among patients aged 80 years or older (hazard ratio [HR], 0.61; 95% CI, 0.40-0.93) and a more pronounced reduction in the risk for major bleeding among those younger than 70 years (HR, 0.23; 95% CI, 0.06-0.79). IN PRACTICE: 'Although the present study did not clarify the factors involved, it is important to reaffirm that rivaroxaban monotherapy effectively reduces net adverse clinical events, which comprehensively include both thrombotic and hemorrhagic events, across a wide age range, even in older patients,' the researchers reported. SOURCE: This study was led by Junichi Yamaguchi, MD, PhD, of the Department of Cardiology at Tokyo Women's Medical University in Tokyo, Japan. It was published online on August 13, 2025, in JAMA Cardiology. LIMITATIONS: The open-label design of the trial may have introduced bias. As a post hoc analysis, this study was underpowered, and differences between the two arms may have been missed due to small sample size. The antiplatelet agent was chosen by the treating physician and was not standardized. DISCLOSURES: This study received support from the Japan Cardiovascular Research Foundation through a contract with Bayer Yakuhin, Ltd. Several authors reported receiving grants, personal fees, and endowments from multiple sources, including Bayer, the Ministry of Education, Culture, Sports, Science and Technology of Japan, and Abbott, among others. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
Yahoo
5 hours ago
- Yahoo
Breastfeeding could help prevent early puberty in girls and boys, South Korean study finds
Girls and boys who were exclusively breastfed during their first four to six months showed a reduced risk of early puberty, according to a large new study from South Korea that Canadian doctors say could apply here. The study, published in Monday's issue of JAMA Network Open, looked back at the diets and development of more than 300,000 children from 2007 to 2020, based on data from checkups at four to six months of age and before six years. Worldwide, puberty has increasingly begun earlier in kids. Called "central precocious puberty," it's linked to an increased risk of health problems in adulthood, like heart disease, cancer and diabetes, as well as mental health issues like depression and anxiety. The researchers believe that kids who are exclusively breastfed are less likely to develop childhood obesity, a major predisposing factor of early puberty. However, experts note that many mothers face challenges in breastfeeding, which they say should be addressed on a structural level. "The take-home message should be, for parents or to-be parents, that breastfeeding has multiple beneficial health effects for their children," said Dr. Sonia Anand, associate vice-president of global health at McMaster University, who was not involved in the study. "And the second message is it is not always easy to do." Long-term benefits of breastfeeding About 46 per cent of the babies in the South Korean study were exclusively breastfed, more than a third had formula and nearly 20 per cent had both. "The idea is that breastfed kids are less likely to have extra weight and that's the mechanism whereby they're more protected from developing early puberty," said Dr. Kaberi Dasgupta, a professor of medicine and physician scientist at the McGill University Health Centre, who also was not involved in the study. Boys who were fed just formula had a 16 per cent increased risk of early puberty compared with their peers who were only fed breast milk, the researchers found. For exclusively formula-fed girls, the association jumped to 60 per cent. For mixed-fed boys, it was 14 per cent higher, compared with 45 per cent for girls. The researchers noted some caveats to their study. The participants self-reported how long they breastfed their children, for example. It also couldn't include genetic factors like maternal age of puberty. The early part of life is a key time, as that's when a lot of disease risk is set, wrote doctors Lin Yang and Shengxu Li. Though they weren't involved in the study, they wrote an accompanying journal commentary. "Disease starts early, so should its prevention," they said. Dasgupta says there's no reason to think the findings would be different in Canada. Preventing early puberty can also help kids in other ways, she adds. "The earlier your puberty, the shorter you may become," she said. "There's also the stigma around having early signs of being an adult when you're still a kid. Other kids may tease you." Supporting mothers instead of shaming Yang and the researchers say that instead of putting pressure on new moms, a society-wide approach is important. That includes stronger parental leave policies, workplace accommodations like a private space to breastfeed and lactation support services. "I think policy support, raised awareness, as well as creating the environment for women to be able to [breastfeed] is very important," Yang told CBC News. Sleep patterns, physical activity levels and screen time could also be increasing childhood obesity and early puberty rates, Yang and Li wrote in their commentary, as well as environmental pollutants like endocrine disruptors, though she acknowledged there isn't good data on that. In Canada, about 91 per cent of parents start out breastfeeding. About 38 per cent of parents breastfed exclusively for at least six months, Statistics Canada reported in 2024. Of those who stopped before six months, reasons included not having enough breast milk, finding breastfeeding difficult and the child weaning themself off of it. "I think the wrong takeaway and the wrong approach is to shame mothers who try to breastfeed but can't continue," Anand said. Breastfeeding is one factor among many that can influence weight gain in kids. Lifestyle choices like limiting fast food and cooking with more vegetables and lean proteins can also help prevent childhood obesity, doctors say. While the South Korean study doesn't prove that formula feeding causes early puberty, the researchers had a robust data set and the associations are plausible, she said. Anand's own research demonstrated early breastfeeding and for at least six months was associated with lower levels of excess body fat in children at age three. She says she'd like to see other large studies show similar findings to the South Korean to nail down cause and effect. Studies looking at how genes are tied to precocious puberty could also help, she said.
